Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01724815
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
IYT | N-ALPHA-ACETYL-3,5-DIIODOTYROSYL- D-THREONINE | A | 1SDW | 0.72 | |
629 | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL- PIPERIDIN-2-YL)- ACETIC ACID | A | 1JIJ | 0.7 | |
AEH | 4-(2-aminoethyl)-2-ethylphenol | A | 3BUG | 0.75 | |
DTY | D-TYROSINE | A | 1C4B | 0.71 | |
DTY | D-TYROSINE | A,L | 1ZEA | 0.71 | |
DTY | D-TYROSINE | A,B,C,D,E,F, G,H | 1OF6 | 0.71 | |
DTY | D-TYROSINE | A,B | 1UNO | 0.71 | |
DTY | D-TYROSINE | A | 2IGZ | 0.71 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5D | 0.71 | |
DTY | D-TYROSINE | A,B | 2Q33 | 0.71 | |
DTY | D-TYROSINE | H,S | 2H9E | 0.71 | |
DTY | D-TYROSINE | A,B,C,H,K,L | 2R5B | 0.71 | |
DTY | D-TYROSINE | A | 2IH0 | 0.71 | |
DTY | D-TYROSINE | A | 1D7T | 0.71 | |
DTY | D-TYROSINE | A,B | 1XA0 | 0.71 | |
D3P | (2R)-AMINO(3,5-DIHYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1W7Q | 0.73 | |
D3P | (2R)-AMINO(3,5-DIHYDROXYPHENYL)ACETIC ACID | A,B,C,D,E,F, G,H | 1W7R | 0.73 | |
CMQ | N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)- 2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]- L-LEUCINAMIDE | A,B,C,D,E,F, G,H,I,J,K,L, M,N | 2FZS | 0.7 | |
BM4 | 3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl- 3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan- 3-yl]phenol | X | 2W6C | 0.71 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.7 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.7 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.7 | |
CJO | [(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]- 4-(4-hydroxybenzyl)-5-oxoimidazolidin- 1-yl]acetic acid | A | 2QT2 | 0.7 | |
485 | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (3,4,5-TRIHYDROXY-6-METHYL-TETRAHYDRO- PYRAN-2-YL)- ACETIC ACID | A | 1JIL | 0.7 | |
ANM | ANISOMYCIN | 1,2,4,A,B,C, D,E,J,K,L,M, N,O,P,R,S,T, U,V,Z | 1K73 | 0.72 | |
ANM | ANISOMYCIN | 0,1,3,9,A,B, C,F,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 3CC4 | 0.72 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.76 | |
LDP | L-DOPAMINE | A | 5PAH | 0.76 | |
LDP | L-DOPAMINE | A,B | 2QMZ | 0.76 | |
LDP | L-DOPAMINE | A,B | 2VQ5 | 0.76 | |
AED | 4-(2-aminoethyl)-2-cyclohexylphenol | A | 3BUH | 0.72 | |
AHT | 4-(2,5-DIAMINO-5-HYDROXY-PENTYL)- PHENOL | I,T | 1TMB | 0.77 | |
HV7 | 1-METHYLAMINE-2-HYDROXY-4-METHOXY- BENZENE | C | 1A8G | 0.74 | |
AEF | 4-(2-aminoethyl)phenol | A | 3BRA | 0.75 | |
CTL | CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN- 1-OL | A,B | 2AN3 | 0.71 | |
AEG | 4-[(2R)-2-aminopropyl]phenol | A | 3BUF | 0.77 | |
CZO | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]- 2-hydroxy-4-(4-hydroxybenzyl)-5- oxoimidazolidin-1-yl]acetic acid | A | 2QRF | 0.7 | |
ALE | L-EPINEPHRINE | A | 3PAH | 0.88 | |
ALE | L-EPINEPHRINE | A | 2HKK | 0.88 |